Loss of suppressor loci on chromosomes 11 and 14 may be required for radiation-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids

Radiation Research

Volumn 149, Issue 3, 1998, Pages 246-255

  Mendonca, Marc S ^a   Howard, Kelly ^a   Fasching, Clare L ^b   Farrington, Daphne L ^a   Desmond, Lael A ^a   Stanbridge, Eric J ^a   Leslie Redpath, J ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME 11; CHROMOSOME 14; CONTROLLED STUDY; GENE LOCATION; GENE LOSS; HELA CELL; HUMAN; HUMAN CELL; HYBRID CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SKIN CANCER; SKIN FIBROBLAST; TUMOR SUPPRESSOR GENE;

ALKALINE PHOSPHATASE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; GENES, INTRACISTERNAL A-PARTICLE; GENES, TUMOR SUPPRESSOR; HELA CELLS; HUMANS; HYBRID CELLS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE DELETION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031939034     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579957     Document Type: Article

References (63)

1. R. R. Weichselbaum, M. A. Beckett and A. A. Diamond, An important step in radiation carcinogenesis may be inactivation of cellular genes. Int. J. Radiat. Oncol. Biol. Phys. 16, 277-282 (1989).
2. P. Thraves, Z. Salehi, A. Dritschilo and J. S. Rhim, Neoplastic transformation of immortalized human epidermal keratinocytes by ionizing radiation. Proc. Natl. Acad. Sci. USA 87, 1174-1177 (1990).
3. J. C. Willey, T. K. Hei, C. Q. Piao, L. Madrid, J. J. Willey, M. J. Apostolakos and B. Hukku, Radiation-induced deletion of chromosomal regions containing tumor suppressor genes in human bronchial epithelial cells. Carcinogenesis 14, 1181-1188 (1993).
4. J. S. Rhim, Neoplastic transformation of human cells in vitro. Crit. Rev. Oncogenesis 4, 313-335 (1993).
5. S. Pazzaglia, X-R. Chen, C. B. Aamodt, S-Q. Wu, C. Kao, K. W. Gilchrist, R. Oyasu, C. A. Reznikoff and M. A. Ritter, In vitro radiation-induced neoplastic progression of low-grade uroepithelial tumors. Radiat. Res. 138, 86-92 (1994).
6. M. S. Mendonca, C. L. Fasching, E. S. Srivatsan, E. J. Stanbridge and J. L. Redpath, Loss of a putative chromosome 11 tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa × fibroblast human cell hybrids. Radiat. Res. 143, 34-44 (1995).
7. J. L. Redpath, M. Mendonca, C. Sun, R. Antoniono, M. Colman, K. M. Latham and E. J. Stanbridge, Tumor suppressor gene inactivation and radiation-induced neoplastic transformation in vitro: Model studies using human hybrid cells. In Radiation Research: A Twentieth-Century Perspective, Vol. II (W. C. Dewey, M. Edington, R. J. M. Fry, E. J. Hall and G. F. Whitmore, Eds.), pp. 342-347. Academic Press, San Diego, 1992.
8. E. J. Stanbridge, Suppression of malignancy in human cells. Nature 260, 17-20 (1976).
9. E. J. Stanbridge, Human tumor suppressor genes. Annu. Rev. Genet. 24, 615-657 (1990).
10. C. Sun, J. L. Redpath, M. Colman and E. J. Stanbridge, Further studies on the radiation-induced expression of a tumor-specific antigen in human cell hybrids. Radiat. Res. 114, 84-93 (1988).
11. M. S. Mendonca, R. J. Antoniono, K. M. Latham, E. J. Stanbridge and J. L. Redpath, Characterization of intestinal alkaline phosphatase expression and the tumorigenic potential of γ-irradiated HeLa × fibroblast cell hybrids. Cancer Res. 51, 4455-4462 (1991).
12. E. J. Stanbridge, R. R. Flandemeyer, D. W. Daniels and W. A. Nelson-Rees, Specific chromosome loss associated with expression of tumorigenicity in human cell hybrids. Somat. Cell Genet. 7, 699-712 (1981).
13. C. J. Der and E. J. Stanbridge, A tumor-specific membrane phosphoprotein marker in human cell hybrids. Cell 26, 429-438 (1981).
14. J. L. Redpath, C. Sun, M. Colman and E. J. Stanbridge, Neoplastic transformation of human hybrid cells by irradiation: A quantitative assay. Radiat. Res. 110, 468-472 (1987).
15. E. J. Stanbridge, C. J. Der, C. J. Doerson, R. Y. Nishimi, D. M. Peehi, B. E. Weissman and J. E. Wilkinson, Human cell hybrids: Analysis of transformation and tumorigenicity. Science 215, 252-259 (1982).
16. E. S. Srivatsan, W. F. Benedict and E. J. Stanbridge, Implication of chromosome 1 in the suppression of neoplastic expression in human cell hybrids. Cancer Res. 46, 6174-6179 (1986).
17. M. Kaelbling and H. P. Klinger, Suppression of tumorigenicity in somatic cells. III. Cosegregation of human chromosome 11 of a normal cell and suppression of tumorigenicity in intraspecies hybrids of normal diploid × malignant cells. Cytogenet Cell Genet. 41, 67-70 (1986).
18. K. M. Latham and E. J. Stanbridge, Identification of the HeLa tumor-associated antigen, p75/150, as intestinal alkaline phosphatase and evidence for its transcriptional regulation. Proc. Natl. Acad. Sci. USA 87, 1263-1267 (1990).
19. M. S. Mendonca, R. J. Antoniono, C. Sun and J. L. Redpath, A simplified and rapid staining method for the HeLa × skin fibroblast human hybrid cell neoplastic transformation assay. Radiat. Res. 131, 345-350 (1992).
20. E. J. Stanbridge and J. Wilkinson, Dissociation of anchorage independence from tumorigenicity in human cell hybrids. Int. J. Cancer 26, 1-8 (1980).
21. D. C. Bicknell, D. R. Sutherland, E. J. Stanbridge and M. F. Greaves, Monoclonal antibodies specific for a tumor-associated membrane phosphoprotein in human cell hybrids. Hybridoma 4, 143-152 (1985).
22. E. M. Southern, Detection of sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98, 503-517 (1975).
23. P. Chomczynski and P. K. Qasaba, Alkaline transfer to a plastic membrane. Biochem. Biophys. Res. Commun. 122, 340-344 (1984).
24. A. P. Feinberg and B. A. Vogelstein, A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137, 266-267 (1983).
25. E. S. Srivatsan, B. C. Misra, M. Venugopalan and S. P. Wilczynski, Loss of heterozygosity for alleles on chromosome 11 in cervical carcinoma. Am. J. Hum. Genet. 49, 868-877 (1991).
26. E. S. Srivatsan, V. Murali and R. C. Seeger, Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma. Prog. Clin. Biol. Res. 366, 91-98 (1991).
27. E. S. Srivatsan, K. L. Ying and R. C. Seeger, Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chromosomes Cancer 7, 32-37 (1993).
28. M. H. Polymeropoulos, H. Xiao, D. S. Rath and C. R. Merril, Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450gene (CYP19). Nucleic Acids Res. 19, 195 (1991).
29. D. Pinkel, T. Straume and J. W. Gray, Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc. Natl. Acad. Sci. USA 83, 2934-2938 (1986).
30. B. C. Misra and E. S. Srivatsan, Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome 11. Am. J. Hum. Genet. 45, 565-577 (1989).
31. R. A. Jesudasan, M. L. Slovak, S. Sen and E. S. Srivatsan, Rearrangement of chromosome band 11q13 in HeLa cells. Anticancer Res. 14, 1727-1734 (1994).
32. R. A. Jesudasan, R. A. Rahman, S. Chandrashekharappa, G. A. Evans and E. S. Srivatsan, Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines. Am. J. Hum. Genet. 56, 705-715 (1995).
33. M. C. Goyette, K. Cho, C. L. Fasching, D. B. Levy, K. W. Kinzler, C. Paraskeva, B. Vogelstein and E. J. Stanbridge, Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol. 12, 1387-1395 (1992).
34. A. J. Knudson, Jr., Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68, 820-823 (1971).
35. E. Rodriguez, C. Sreekantaiah and R. S. K. Chaganti, Genetic changes in epithelial solid neoplasia. Cancer Res. 54, 3398-3406 (1994).
36. R. A. Weinberg, The molecular basis of oncogenes and tumor suppressor genes. Ann. NY Acad. Sci. 758, 331-338 (1995).
37. M. Sasaki, M. Okamoto, C. Sato, K. Sugio, J-I. Soejima, T. Iwama, T. Ikeuchi, A. Tonomura, M. Miyaki and T. Sasazuki, Loss of constitutional heterozygosity in colorectal tumors from patients with familial polyposis coli and those with nonpolyposis colorectal carcinoma Cancer Res. 49, 4402-4406 (1989).
38. W. Cliby, S. Ritland, L. Hartmann, M. Dodson, K. C. Hailing, G. Keeney, K. C. Podratz and R. B. Jenkins, Human epithelial ovarian cancer allelotype. Cancer Res. 53, 2393-2398 (1993).
39. J. Young, B. Leggett, M. Ward, L. Thomas, R. Buttenshaw, J. Searle and G. Chenevix-Trench, Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas. Oncogene 8, 671-675 (1993).
40. H. Nawroz, P. van der Riet, R. H. Hruban, W. Koch, J. M. Ruppert and D. Sidransky, Allelotype of head and neck squamous cell carcinoma. Cancer Res. 54, 1152-1155 (1994).
41. W. Y-H. Chang, P. Cairns, M. P. Schoenberg, T. J. Polascik and D. Sidransky, Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res. 55, 3246-3249 (1995).
42. T. Fujino, J. I. Risinger, J. K. Collins, F-S. Liu, H. Nishii, H. Takahashi, E-M. Westphal, J. C. Barren, H. Sasaki, M. F. Kohler, A. Berchuck and J. Boyd, Allelotype of endometrial carcinoma. Cancer Res. 54, 4294-4298 (1994).
43. M. Koi, H. Morita, H. Yamada, H. Satoh, J. C. Barrett and M. Oshimura, Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa. Mol. Carcinogen. 2, 12-21 (1989).
44. D. Rasio, G. Manenti, T. A. Dragani and C. M. Croce, Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: Identification of three independent regions. Cancer Res. 55, 3988-3991 (1995).
45. M. E. Shaw and M. A. Knowles, Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chromosomes Cancer 13, 1-8 (1995).
46. D. S. Heo, C. Synderman, S. M. Gollin, S. Pan, E. Walker, R. Deka, E. L. Barnes, J. T. Johnson, R. B. Herberman and T. L. Whiteside, Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res. 49, 5167-5175 (1989).
47. P. L. Keldysh, T. A. Dragani, E. W. Fleischman, L. N. Konstantinova, A. G. Perevosehikova, M. A. Pierotti, G. Delia Porta and B. P. Kopnin, 11q deletions in human colorectal carcinomas: Cytogenetics and restriction length polymorphisms. Genes Chromosomes Cancer 6, 45-50 (1993).
48. G. M. Hampton, L. A. Penny, R. M. Baergen, A. Larson, C. Brewer, S. Liao, R. M. C. Busby-Earle, A. W. R. Williams, C. M. Steel, C. C. Bird, E. J. Stanbridge and G. A. Evans. Loss of heterozygosity in cervical carcinoma: Subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q2-q24. Proc. Natl. Acad. Sci. USA 91, 6953-6957 (1994).
49. A. B. Y. Hui, K-W. Lo, S-F. Leung, P. H. K. Choi, Y. Fong, J. C. K. Lee and D. P. Huang, Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res. 56, 3225-3229 (1996).
50. H. Gabra, J. E. V. Watson, K. J. Taylor, J. Mackay, R. C. F. Leonard, C. M. Steel, D. J. Porteous and J. F. Smith, Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res. 56, 950-954 (1996).
51. D. Gioeli, K. Conway and B. E. Weissinan, Localization and characterization of a chromosome 11 tumor suppressor gene using organotypic raft cultures. Cancer Res. 57, 1157-1165 (1997).
52. J. A. Boyd and J. C. Barrett, Genetic and cellular basis of multistep carcinogenesis. Pharmacol. Ther. 46, 469-486 (1990).
53. L. A. Loeb, Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075-3079 (1991).
54. K. C. Cheng and L. A. Loeb, Genomic instability and tumor progression: mechanistic considerations. Adv. Cancer Res. 60, 121-156 (1993).
55. C. Lengauer, K. W. Kinzler and B. Vogelstein, Genetic instability in colorectal cancers. Nature 386, 623-627 (1997).
56. M. S. Mendonca, R. J. Antoniono and J. L. Redpath, Delayed heritable damage and epigenetics in radiation-induced neoplastic transformation of human hybrid cells. Radiat. Res. 134, 209-219 (1993).
57. W. F. Morgan, J. P. Day, M. I. Kaplan, E. M. McGhee and C. L. Limoli, Genomic instability induced by ionizing radiation. Radiat. Res. 146, 247-258 (1996).
58. C. Mothersill, F. Lyng, S. O'Reilly, J. Harney and C. B. Seymour, Expression of lethal mutations is suppressed in neoplastically trans formed cells and after treatment of normal cells with carcinogens. Radiat. Res. 145, 714-721 (1996).
59. J. P. Murnane, Role of induced genetic instability in the mutagenic effects of chemicals and radiation. Mutat. Res. 367, 11-23 (1996).
60. J. P. Murnane, The role of recombinational hotspots in genome instability in mammalian cells: A historical perspective. Bioassays 12, 577-581 (1990).
61. B. A. Marder and W. F. Morgan, Delayed chromosomal instability induced by DNA damage. Mol. Cell. Biol. 13, 6667-6677 (1993).
62. P. W. Hinds, The retinoblastoma tumor suppressor protein. Curr. Opin. Genet. Dev. 5, 79-83 (1995).
63. L. J. Ko and C. Prives, p53: Puzzle and paradigm. Genes Dev. 10, 1054-1072 (1996).